Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-15
2005-02-15
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210210, C514S422000, C540S461000
Reexamination Certificate
active
06855705
ABSTRACT:
Compounds having a structure according to formula Iwherein the groups R1and R4are as defined in the specification, are useful as anti-proliferative agents.
REFERENCES:
patent: 3987035 (1976-10-01), Rinehart, Jr. et al.
patent: 4261989 (1981-04-01), Sasaki et al.
patent: 4421687 (1983-12-01), Hasegawa et al.
patent: 4421688 (1983-12-01), Muroi et al.
patent: 4540517 (1985-09-01), Tanida et al.
patent: 5387584 (1995-02-01), Schnur
patent: 5510118 (1996-04-01), Bosch et al.
patent: 5534270 (1996-07-01), De Castro
patent: 5662883 (1997-09-01), Bagchi et al.
patent: 5932566 (1999-08-01), Schnur et al.
patent: 6015659 (2000-01-01), Welch et al.
patent: 6682758 (2004-01-01), Tabibi et al.
patent: 20030114450 (2003-06-01), Santi et al.
patent: 63-218620 (1988-09-01), None
patent: 04-046120 (1992-02-01), None
patent: WO 9314215 (1993-07-01), None
patent: WO 9408578 (1994-04-01), None
patent: WO 9501342 (1995-01-01), None
patent: WO 0003737 (2000-01-01), None
patent: WO 0236574 (2002-05-01), None
patent: WO 02079167 (2002-10-01), None
patent: WO 03013430 (2003-02-01), None
patent: WO 03066005 (2003-08-01), None
Sasaki et al.,J. Antibiotics32 (8), 849-851 (1979), “Growth Inhibition of Virus Transformed Cells in Vitro and Antitumor Activity in Vivo of Geldanamycin and its Derivatives”.
Muroi et al.,Tetrahedron37, 1123-1130 (1981), “The Structures of Macbecins I and II”.
Omura et al.,J. Antibiotics37 (10), 1264-1267 (1984), “Chemical Modification and Antitumor Activity of Herbimycin A, 8,9-Epoxide, 7,9-Cyclic Carbarnate, and 17- or 19-Amino Derivatives”.
Shibata et al.,J. Antibiotics39 (11), 1630-1633 (1986), “The Structure and Cytocidal Activity of Herbimycin C”.
Uehara et al.,J. Antibiotics41 (5), 831-834 (1988), “Effects of Herbimycin Derivatives on src Oncogene Function in Relation to Antitumor Activity”.
Schnur et al.,J. Med. Chem., 38, 3806-3812 (1995), “Inhibition of Oncogene Products p185 (erbB-2) in Vitro by Geldanamycin and Dihydrogeldanamycin Derivatives”.
Schnur et al.,J. Med. Chem., 38, 3813-3820 (1995), “erbB-2 Oncogene Inhibition by Geldanamycin Derivatives: Synthesis, Mechanism of Action, and Structure-Activity Relationships”.
Jez et al.,Chemistry&Biology, 10,361-368 (2003), “Crystal Structure and Molecular Modeling of 17-DMAG in Complex with Human Hsp90”.
Carreras et al.,Anal. Biochem., 317 (1), 40-46 (Jun. 2003), “Filter Binding Assay for the Geldanamycin-Heat Shock Protein 90 Interaction”.
Chemical Abstracts 110:231340 (abstract of JP 63-218620).
Chemical Abstracts 117:63002 (abstract of JP 04-046120).
Liu Yaoquan
Myles David C.
Tian Zong-Qiang
Wang Zhan
Chao Yuan
Kifle Bruck
Kosan Biosciences, Inc.
LandOfFree
11-O-methylgeldanamycin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11-O-methylgeldanamycin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11-O-methylgeldanamycin compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3450887